Screener
Xenon Pharmaceuticals XENE Total Revenue
Total Revenue at other companies
Other financials
Where this comes from
Reported directly by Xenon Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Collaboration revenue (note 9) | — | — | — | $7,500 |
| Operating expenses: | ||||
| Research and development | 99,224 | 74,985 | 187,732 | 136,185 |
| General and administrative | 23,931 | 19,244 | 47,751 | 38,282 |
| Total operating expenses | 123,155 | 94,229 | 235,483 | 174,467 |
| Loss from operations | (123,155) | (94,229) | (235,483) | (166,967) |
| Other income: | ||||
| Interest income | 12,145 | 7,199 | 19,052 | 15,282 |
Item 1. Financial Statements
FAQ
- What is Xenon Pharmaceuticals's total revenue?
- Xenon Pharmaceuticals (XENE) reported total revenue of $0 in Q2 2026.
- What is the long-term trend for Xenon Pharmaceuticals's total revenue?
- Over 4 years (2021 to 2025), Xenon Pharmaceuticals's total revenue has grown at a -20.1% compound annual growth rate (CAGR), from $18.44M to $7.5M.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about Xenon Pharmaceuticals's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude